MICRO MN 0.1 MG
MANGANESE (MANGANESE SULFATE) : 0.1 MG · DIN 00786942 · SANDOZ CANADA INCORPORATED
Health Canada status: MARKETED
What is MICRO MN?
MICRO MN 0.1 MG contains MANGANESE (MANGANESE SULFATE) : 0.1 MG. It is listed in the Health Canada Drug Product Database under DIN 00786942, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 29-Jul-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MICRO MN used for?
Supplement to intravenous solutions for total parenteral nutrition (TPN) to maintain plasma manganese levels and prevent depletion of endogenous stores and deficiency symptoms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00786942 |
|---|---|
| Brand name | MICRO MN |
| Generic / active ingredient | MANGANESE (MANGANESE SULFATE) : 0.1 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 0.1 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | A12CX OTHER MINERAL PRODUCTS |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Jul-2006 |
| Original market date | 1992-12-31 00:00:00 |
How is it administered?
Adults: 0.15 to 0.8 mg/day. Pediatrics: Dosage based on weight (≤1 mcg/kg/day to 15 mcg/kg/day). Administer by intravenous infusion after dilution only.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 15 and 28ºC. Protect from freezing. After dilution, use within 24 hours.
How is it supplied?
Single use vials of 10 mL, boxes of 10. Stopper is not made with natural rubber latex.
Contraindications
Hypersensitivity to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
Warnings and precautions
Hypotonic solution; must be diluted. Do not give by direct injection (risk of phlebitis). Excess manganese can lead to brain deposition and Parkinson-like/neuropsychiatric symptoms.
What can be used instead?
Other Canadian products sharing ATC code A12CX OTHER MINERAL PRODUCTS. 5 of 75 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MICRO CR | 4 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00786985 |
| MICRO CU | 0.4 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00786969 |
| MICRO I | 100 MCG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 01974548 |
| MICRO SE | 40 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 01986007 |
| ACTI-I CAPLET | 0.225 MG | TABLET | ACTI-FORM LTD. | CANCELLED POST MARKET | DIN 00899127 |
| ACTICHROM | 200 MCG | TABLET | NUTRACEUTICAL CORPORATION | CANCELLED (UNRETURNED ANNUAL) | DIN 02241135 |
| ACTYFORM | 1 MG | CAPSULE | TECHNODIET S.E.N.C. | CANCELLED POST MARKET | DIN 02240282 |
| BIO-CHROME | 200 MCG | CAPSULE | SANTÉ NATURELLE (AG) LTÉE | CANCELLED POST MARKET | DIN 02241894 |
| BIO-PLEX TAB 0.95MG | .95 MG | TABLET | THERAPEUTIC FOODS CO. | CANCELLED POST MARKET | DIN 00760625 |
| CALCIUM & MAGNESIUM PLUS POTASSIUM & ZINC | 250 MG | TABLET | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | CANCELLED POST MARKET | DIN 02248650 |
Who else supplies OTHER MINERAL PRODUCTS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OTHER MINERAL PRODUCTS appears in 8 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.